An innovative and reliable approach using monocyte-derived hepatocyte-like (MH) cells has demonstrated high sensitivity and specificity in the diagnosis of idiosyncratic drug-induced liver injury (iDILI), according to data presented at the International Digestive Disease Forum (IDDF) organized by the Chinese University of Hong Kong (CUHK).
Vonoprazan, a novel potassium-competitive acid blocker (P-CAB), is at least as effective as proton-pump inhibitors (PPIs) in the treatment of acid-related disorders, according to results of Japanese studies reported at the International Digestive Disease Forum (IDDF) 2019.
Asia's trusted medical magazine for healthcare professionals.
Get your MIMS Doctor - Malaysia digital copy today!
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.